What is the equity of Carasent A this year?
Carasent A has equity of 955.41 M NOK this year.
In 2024, Carasent A's equity was 955.41 M NOK, a -22.11% increase from the 1.23 B NOK equity in the previous year.
Carasent A's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Carasent A's equity is essential for assessing its financial health, stability, and value to shareholders.
Evaluating Carasent A's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Carasent A's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Fluctuations in Carasent A’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Carasent A has equity of 955.41 M NOK this year.
The equity of Carasent A has increased/decreased by -22.11% decreased compared to the previous year.
A high equity is advantageous for investors of Carasent A as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
A low equity can be a risk for investors of Carasent A, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
An increase in equity of Carasent A can strengthen the company's financial position and improve its ability to make investments in the future.
A reduction in equity of Carasent A can affect the financial situation of the company and lead to a higher dependence on debt capital.
Some factors that can affect the equity of Carasent A include profits, dividend payments, capital increases, and acquisitions.
The equity of Carasent A is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
To change equity, Carasent A can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
Over the past 12 months, Carasent A paid a dividend of 1.84 NOK . This corresponds to a dividend yield of about 9.51 %. For the coming 12 months, Carasent A is expected to pay a dividend of 1.84 NOK.
The current dividend yield of Carasent A is 9.51 %.
Carasent A pays a quarterly dividend. This is distributed in the months of December, January, June, December.
Carasent A paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 1.84 NOK are expected. This corresponds to a dividend yield of 9.5 %.
Carasent A is assigned to the 'Health' sector.
To receive the latest dividend of Carasent A from 11/23/2023 amounting to 1.84 NOK, you needed to have the stock in your portfolio before the ex-date on 11/15/2023.
The last dividend was paid out on 11/23/2023.
In the year 2023, Carasent A distributed 0 NOK as dividends.
The dividends of Carasent A are distributed in NOK.
Our stock analysis for Carasent A Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Carasent A Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.